cfDNA in exhaled breath condensate (EBC) and contamination by ambient air: toward volatile biopsies
Altuğ Koç, Tuncay Göksel, Levent Pelit, Korcan Korba, Tuğberk Nail Dizdaş, Ertan Baysal, Umut Can Uzun, Özge Özer Kaya, et al. (16 authors)
Journal of Breath Research · 2019-04
Abstract
Abstract Exhaled breath is a source of volatile and nonvolatile biomarkers in the body that can be accessed non-invasively and used for monitoring. The collection of lung secretions by conventional methods such as bronchoalveolar lavage, induced sputum collection, and core biopsies is limited by the invasive nature of these methods. Non-invasive collection of exhaled breath condensate (EBC) provides fluid samples that are representative of airway lining fluids. Various volatile and nonvolatile biomarkers can be detected in volatile condensates, such as H 2 O 2 , nitric oxide, lipid mediators, cytokines, chemokines, DNA, and microRNAs. Studies have examined cell-free DNA (cfDNA) in plasma samples from non-small-cell lung cancer patients, offering to new insights and fostering development of the liquid biopsy. However, few studies have examined cfDNA in EBC samples. This study examined whether EBC is an appropriate source of cfDNA using housekeeping-gene-specific primer probes and quantitative real-time polymerase chain reaction in healthy subjects. Ambient (room) air is contaminated with DNA, so caution is needed. Preliminary studies indicated that volatile biopsies are becoming an important diagnostic tool in lung cancer.
MeSH terms
- Exhaled breath condensate
- Bronchoalveolar lavage
- Sputum
- Breath gas analysis
- Lung cancer
- Liquid biopsy
- Chemistry
- Pathology
- Biomarker
- Exhalation
- Polymerase chain reaction
- Exhaled nitric oxide
- Medicine
- Lung